# SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study

> **NCT04832945** · — · COMPLETED · sponsor: **Grupo Rescue S.A.S República Dominicana** · enrollment: 713 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin 6 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT04832945
- **Lead sponsor:** Grupo Rescue S.A.S República Dominicana
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-29
- **Primary completion:** 2020-09-20
- **Final completion:** 2021-04-10
- **Target enrollment:** 713 (ACTUAL)
- **Last updated:** 2021-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04832945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04832945, "SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04832945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*